Literature DB >> 30102624

Current concept of transurethral resection of bladder cancer: from re-transurethral resection of bladder cancer to en-bloc resection.

Jan Schraml1,2, Joana Do Carmo Silva2, Marko Babjuk2,1.   

Abstract

PURPOSE OF REVIEW: Transurethral resection of bladder cancer (TURB) is the critical step in the management of nonmuscle invasive bladder cancer (NMIBC). This review presents new improvements in the strategy and technique of TURB as well as in technological developments used for tumour visualization and removal. RECENT
FINDINGS: The goal of TURB is to perform complete resection of NMIBC. Tumor visualization during procedure can be improved by enhanced optical technologies. Fluorescence-guided photodynamic diagnosis (PDD) and narrow-band imaging (NBI) used during TURB can improve tumour detection and potentially reduce recurrence rate, their influence on progression, however, remains controversial. TURB can be performed using monopolar or bipolar electrocautery without significant differences in results or safety. To overcome limitations of traditional TURB, the technique of en-bloc resection was introduced to improve the quality of tumour removal. In selected cases, an early re-resection (re-TURB) within 2-6 weeks after initial procedure is recommended.
SUMMARY: TURB is a fundamental step in diagnosis and treatment of NMIBC. Urologists should be aware of promising innovations including new imaging and surgical techniques and their potential benefits. Hopefully, new technologies and performance of TURB bring improved outcomes, which can alter the indication criteria for re-TURB.

Entities:  

Mesh:

Year:  2018        PMID: 30102624     DOI: 10.1097/MOU.0000000000000542

Source DB:  PubMed          Journal:  Curr Opin Urol        ISSN: 0963-0643            Impact factor:   2.309


  6 in total

1.  A clinical study of a CD44v6-targeted fluorescent agent for the detection of non-muscle invasive bladder cancer.

Authors:  Wenting Shang; Li Peng; Kunshan He; Pengyu Guo; Han Deng; Yu Liu; Ziyin Chen; Jie Tian; Wanhai Xu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-02-21       Impact factor: 10.057

2.  Systematic review and meta-analysis on bipolar versus monopolar transurethral resection of bladder tumors.

Authors:  Wojciech Krajewski; Łukasz Nowak; Marco Moschini; Andrea Mari; Ettore Di Trapani; Evanguelos Xylinas; Andrzej Tukiendorf; Sławomir Poletajew; Romuald Zdrojowy
Journal:  Transl Androl Urol       Date:  2021-01

Review 3.  Transurethral resection of bladder tumour (TURBT).

Authors:  Lawrence H C Kim; Manish I Patel
Journal:  Transl Androl Urol       Date:  2020-12

4.  1470 nm/980 nm dual-wavelength laser is safe and efficient for the en-bloc resection of non-muscle invasive bladder cancer: A propensity score-matched analysis.

Authors:  Jianhan Fu; Fajun Fu; Yinhuai Wang
Journal:  J Int Med Res       Date:  2021-12       Impact factor: 1.671

5.  The Safety and Efficacy of Vela Laser En-Bloc Endoscopic Resection versus Conventional Transurethral Resection of Bladder Tumor-A Single Center Experience.

Authors:  Che-Wei Chang; Tsz-Yi Tang; Jiun-Hung Geng; Jhen-Hao Jhan; Hsun-Shuan Wang; Jung-Tsung Shen; Yung-Chin Lee
Journal:  J Clin Med       Date:  2022-09-05       Impact factor: 4.964

6.  Long-term Follow-up After En Bloc Transurethral Resection of Non-muscle-invasive Bladder Cancer: Results from a Single-center Experience.

Authors:  Marco Paciotti; Paolo Casale; Piergiuseppe Colombo; Vittorio Fasulo; Alberto Saita; Giovanni Lughezzani; Roberto Contieri; Nicolò Maria Buffi; Massimo Lazzeri; Giorgio Guazzoni; Rodolfo Hurle
Journal:  Eur Urol Open Sci       Date:  2021-02-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.